Molecular Pharmaceutics
[ASAP] Effect of Paclitaxel Stereochemistry on X‑ray-Triggered Release of Paclitaxel from CaWO<sub>4</sub>/Paclitaxel-Coloaded PEG-PLA Nanoparticles
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00148
Molecular Pharmaceutics
[ASAP] Synchronization of Cocrystal Dissolution and Drug Precipitation to Sustain Drug Supersaturation
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00122
Molecular Pharmaceutics
[ASAP] Surface Mobility of Amorphous Indomethacin Containing Moisture and a Surfactant: A Concentration–Temperature Superposition Principle
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00311
Molecular Pharmaceutics
[ASAP] Phase-Field Model for Drug Release of Water-Swellable Filaments for Fused Filament Fabrication
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00217
Molecular Pharmaceutics
[ASAP] Peptide-Modified Gemini Surfactants as Delivery System Building Blocks with Dual Functionalities for Glaucoma Treatment: Gene Carriers and Amyloid-Beta (Aβ) Self-Aggregation Inhibitors
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00088
Molecular Pharmaceutics
[ASAP] Design of Ternary Amorphous Solid Dispersions for Enhanced Dissolution of Drug Combinations
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00307
Molecular Pharmaceutics
[ASAP] Voices in Molecular Pharmaceutics: Meet Dr. Paroma Chakravarty, a Solid-State Detective Investigating Which Polymorphs Are Developable
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00470
Molecular Pharmaceutics
[ASAP] Dynamics of Human Serum Transferrin in Varying Physicochemical Conditions Explored by Using Molecular Dynamics Simulations
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00158
Molecular Pharmaceutics
[ASAP] Predicting Bile and Lipid Interaction for Drug Substances
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00227
Molecular Pharmaceutics
[ASAP] PET Imaging of Lung Cancers in Precision Medicine: Current Landscape and Future Perspective
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00353